234 related articles for article (PubMed ID: 29872622)
21. Tanshinone IIA-loaded reconstituted high density lipoproteins: Atherosclerotic plaque targeting mechanism in a foam cell model and pharmacokinetics in rabbits.
Zhang W; Li J; Liu J; Wu Z; Xu Y; Wang J
Pharmazie; 2012 Apr; 67(4):324-30. PubMed ID: 22570939
[TBL] [Abstract][Full Text] [Related]
22. Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy.
Raut S; Mooberry L; Sabnis N; Garud A; Dossou AS; Lacko A
Front Pharmacol; 2018; 9():1154. PubMed ID: 30374303
[TBL] [Abstract][Full Text] [Related]
23. A dual-targeting reconstituted high density lipoprotein leveraging the synergy of sorafenib and antimiRNA21 for enhanced hepatocellular carcinoma therapy.
Li M; Su Y; Zhang F; Chen K; Xu X; Xu L; Zhou J; Wang W
Acta Biomater; 2018 Jul; 75():413-426. PubMed ID: 29859368
[TBL] [Abstract][Full Text] [Related]
24. Rational Design of Lovastatin-Loaded Spherical Reconstituted High Density Lipoprotein for Efficient and Safe Anti-Atherosclerotic Therapy.
Jiang C; Qi Z; Tang Y; Jia H; Li Z; Zhang W; Liu J
Mol Pharm; 2019 Jul; 16(7):3284-3291. PubMed ID: 31117743
[TBL] [Abstract][Full Text] [Related]
25. Dual-functional bio-derived nanoparticulates for apoptotic antitumor therapy.
Ding Y; Wang Y; Opoku-Damoah Y; Wang C; Shen L; Yin L; Zhou J
Biomaterials; 2015 Dec; 72():90-103. PubMed ID: 26344366
[TBL] [Abstract][Full Text] [Related]
26. Validation of the reconstituted high-density lipoprotein (rHDL) drug delivery platform using dilauryl fluorescein (DLF).
McConathy WJ; Paranjape S; Mooberry L; Buttreddy S; Nair M; Lacko AG
Drug Deliv Transl Res; 2011 Apr; 1(2):113-20. PubMed ID: 25788110
[TBL] [Abstract][Full Text] [Related]
27. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
[TBL] [Abstract][Full Text] [Related]
28. Lipoprotein-based nanoparticles rescue the memory loss of mice with Alzheimer's disease by accelerating the clearance of amyloid-beta.
Song Q; Huang M; Yao L; Wang X; Gu X; Chen J; Chen J; Huang J; Hu Q; Kang T; Rong Z; Qi H; Zheng G; Chen H; Gao X
ACS Nano; 2014 Mar; 8(3):2345-59. PubMed ID: 24527692
[TBL] [Abstract][Full Text] [Related]
29. Reassembly of native components with donepezil to execute dual-missions in Alzheimer's disease therapy.
Zhang H; Zhao Y; Yu M; Zhao Z; Liu P; Cheng H; Ji Y; Jin Y; Sun B; Zhou J; Ding Y
J Control Release; 2019 Feb; 296():14-28. PubMed ID: 30639387
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic applications of reconstituted HDL: When structure meets function.
Darabi M; Guillas-Baudouin I; Le Goff W; Chapman MJ; Kontush A
Pharmacol Ther; 2016 Jan; 157():28-42. PubMed ID: 26546991
[TBL] [Abstract][Full Text] [Related]
31. Reconstituted HDL elicits marked changes in plasma lipids following single-dose injection in C57Bl/6 mice.
Chen Z; O'Neill EA; Meurer RD; Gagen K; Luell S; Wang SP; Ichetovkin M; Frantz-Wattley B; Eveland S; Strack AM; Fisher TS; Johns DG; Sparrow CP; Wright SD; Hubbard BK; Carballo-Jane E
J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):315-23. PubMed ID: 22067613
[TBL] [Abstract][Full Text] [Related]
32. Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimer.
Calabresi L; Canavesi M; Bernini F; Franceschini G
Biochemistry; 1999 Dec; 38(49):16307-14. PubMed ID: 10587455
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E3-mediated cellular uptake of reconstituted high-density lipoprotein bearing core 3, 10, or 17 nm hydrophobic gold nanoparticles.
Chuang ST; Shon YS; Narayanaswami V
Int J Nanomedicine; 2017; 12():8495-8510. PubMed ID: 29225464
[TBL] [Abstract][Full Text] [Related]
34. A quantitative
Pedersbæk D; Jønsson K; Madsen DV; Weller S; Bohn AB; Andresen TL; Simonsen JB
RSC Adv; 2020 Jan; 10(7):3884-3894. PubMed ID: 35492676
[TBL] [Abstract][Full Text] [Related]
35. High-density lipoprotein as a potential carrier for delivery of a lipophilic antitumoral drug into hepatoma cells.
Lou B; Liao XL; Wu MP; Cheng PF; Yin CY; Fei Z
World J Gastroenterol; 2005 Feb; 11(7):954-9. PubMed ID: 15742395
[TBL] [Abstract][Full Text] [Related]
36. A Simple Method to Extract Whole Apolipoproteins for the Preparation of Discoidal Recombined High Density Lipoproteins as Bionic Nanocarriers for Drug Delivery.
Zhang W; Wang J; Jia J; Chen L; Wu Z; Liu J
J Pharm Pharm Sci; 2015; 18(2):184-98. PubMed ID: 26158284
[TBL] [Abstract][Full Text] [Related]
37. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.
Ding Y; Wang Y; Zhou J; Gu X; Wang W; Liu C; Bao X; Wang C; Li Y; Zhang Q
Biomaterials; 2014 Aug; 35(25):7214-27. PubMed ID: 24875759
[TBL] [Abstract][Full Text] [Related]
38. Enhanced Antiatherosclerotic Efficacy of Statin-Loaded Reconstituted High-Density Lipoprotein via Ganglioside GM1 Modification.
Wang K; Yu C; Liu Y; Zhang W; Sun Y; Chen Y
ACS Biomater Sci Eng; 2018 Mar; 4(3):952-962. PubMed ID: 33418777
[TBL] [Abstract][Full Text] [Related]
39. PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles.
Pérez-Medina C; Tang J; Abdel-Atti D; Hogstad B; Merad M; Fisher EA; Fayad ZA; Lewis JS; Mulder WJ; Reiner T
J Nucl Med; 2015 Aug; 56(8):1272-7. PubMed ID: 26112022
[TBL] [Abstract][Full Text] [Related]
40. Dual-modified natural high density lipoprotein particles for systemic glioma-targeting drug delivery.
Cui L; Wang Y; Liang M; Chu X; Fu S; Gao C; Liu Q; Gong W; Yang M; Li Z; Yu L; Yang C; Su Z; Xie X; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1865-1876. PubMed ID: 30474437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
